Navigation Links
Hospira to Present at Upcoming Investor Conferences
Date:2/14/2011

LAKE FOREST, Ill., Feb. 14, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced that the company will present at two upcoming conferences:


  • Raymond James 32nd Institutional Investors Conference


  • March 8, 2011 (Tuesday) – Orlando, Fla.  9:15 a.m. Eastern time


  • Barclays Capital 2011 Global Healthcare Conference


  • March 16, 2011 (Wednesday) – Miami, Fla.:45 a.m. Eastern timeThe presentations will be available to all interested parties through live audiocasts accessible via the investor relations section of Hospira's Web site at www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance of each presentation to ensure proper setup to receive the audiocast. The slides accompanying the presentations will also be available on the Hospira Web site. Replays of the webcasts will be available on the Hospira Web site approximately 24 hours after the live presentations.

    Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 14,000 employees. Learn more at www.hospira.com.


    '/>"/>
    SOURCE Hospira, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1

    Related medicine technology :

    1. Hospira Announces FDA Approval of Topotecan Injection
    2. Hospira Reports Fourth-Quarter and Full-Year 2010 Results
    3. Hospira to Host Conference Call for Fourth-Quarter 2010 Results and 2011 Projections
    4. Hospira Launches Piperacillin and Tazobactam for Injection in the United States
    5. Hospira Announces New Contracts in Effect with Novation for Infusion Pumps, Solutions and Equipment
    6. Hospira to Host Conference Call for Third-Quarter 2010 Results
    7. Hospira Receives TGA Approval for Nivestim™, Australias First Biosimilar Filgrastim
    8. Hospira Japan Receives Approval for New Indication for Precedex IV™ 200ug
    9. Hospira Announces CEO Succession Plan
    10. Hospira to Present at Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference Aug. 12
    11. Hospira Begins Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/3/2016)... 3, 2016   Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that it is celebrating Hepatitis ... of two patients who tell their personal story and encourage those at risk to get ... Jacque: Hepatitis C ... ... Diplomat Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.) ...
    (Date:5/3/2016)... -- Forté Elements, LLC (Forté) is excited to announce the launch of its Mediceutical line ... of recovery for a variety of clinical conditions. Founded in 2013, Forté spent more ... Logo -  http://photos.prnewswire.com/prnh/20160502/362547LOGO ... ... ...
    (Date:5/2/2016)... NEW YORK , May 2, 2016 /PRNewswire/ ... Series B financing of Graybug Vision, Inc. Graybug ... to developing therapies that may transform care for ... and glaucoma.  Graybug Vision,s technology was first developed ... out into a startup venture. ...
    Breaking Medicine Technology:
    (Date:5/4/2016)... ... ... Mother Nature isn’t the only mom that loves the garden. Mothers everywhere love ... women with more than just a bouquet of flowers. Give mom, or any special ... Vibrant, Edible, Compact Plants from BrazelBerries: , For a gift that adds year-round color ...
    (Date:5/4/2016)... ... May 04, 2016 , ... World ... the Everlasting Glove, a sports invention that aids in the improvement of the ... industry is worth $9 billion," says Scott Cooper, CEO and Creative Director of ...
    (Date:5/4/2016)... CO (PRWEB) , ... May 04, 2016 , ... ... of observational and interview techniques, seeks to add a deeper understanding of the ... strengths and weaknesses, and each answers different yet important questions. , In a ...
    (Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... children has donated 100 of its innovative kicking trainers to St. Jude Children’s ... The SOCKIT is a durable, lightweight rubber band designed to teach children how ...
    (Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... million in grants to identify, fund and implement ideas aimed at improving care ... Medicaid. , “Part of our vision for Trinity Health is to drive ...
    Breaking Medicine News(10 mins):